POSTERS
![](https://www.netramark.com/wp-content/uploads/2024/05/image-37.png)
Introducing the Treatment Attitude Profile (TAP) Scale for Placebo Response Persona Discovery Using Attractor AI Technologies: Applications in Clinical Trial Patient Enrichment
![](https://www.netramark.com/wp-content/uploads/2024/04/image-14.jpg)
The power of NetraAI: Precision medicine in oncology through sub-insight learning from small data sets
![](https://www.netramark.com/wp-content/uploads/2024/04/NetraAI-driven-discorvery.jpg)
NetraAI-driven discovery of novel biomarkers in MSI-high colon cancer for precision immunotherapy
![](https://www.netramark.com/wp-content/uploads/2024/03/image-13.jpg)
Using NetraAI to Discover Parkinson’s Disease Subtypes: Generative AI Reveals Transcriptomic Personas Linking Mitochondrial, Microbiome, and Immune Signaling
![](https://www.netramark.com/wp-content/uploads/2024/02/Elevating.jpg)
Evaluating Drug Efficacy: Leveraging Machine Learning Insights For Placebo Response Modeling
![](https://www.netramark.com/wp-content/uploads/2024/02/Identifying.jpg)
Identifying Efficacy Variables for the Use of Escitalopram in Mild Major Depression Disorder (MDD): Implications for Treatment-Resistant MDD Trials
![](https://www.netramark.com/wp-content/uploads/2023/11/CNS-Summit.jpg)
NetraAI: Understanding Patient Populations Beyond Disease Labels for De-Risking Clinical Trials with Large Language Models
![](https://www.netramark.com/wp-content/uploads/2023/11/Presentation.jpg)
Uncovering an Association Between Oligodendroglioma and the Human Papillomavirus (HPV) Through Molecular Subpopulation Analysis Using NetraAI
![](https://www.netramark.com/wp-content/uploads/2023/10/New-Project-2023-10-06T103737.768.jpg)
Understanding treatment response in pancreatic cancer: NetraAI provides genetic differentiation in FOLFIRINOX and Gemcitabine response
![](https://www.netramark.com/wp-content/uploads/2023/10/New-Project-2023-10-06T103630.603.jpg)
Using AI on Data from Anxiety and Schizophrenia Trials to Identify Causal Clusters of Variables for Drug & Placebo Response Via Long Range Memory to Improve Clinical Trial Outcomes
![](https://www.netramark.com/wp-content/uploads/2023/06/ALSposterpic.png)
Using NetraAI Hypothesis-Generation for Patient Stratification and Target Discovery in ALS
![](https://www.netramark.com/wp-content/uploads/2023/06/alslimbvsbulbarposterpic.png)